BIIB
NASDAQ · Biotechnology
Biogen Inc
$201.96
+2.37 (+1.19%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+14.21%
1Y
+59.12%
YTD
+13.58%
Open$201.63
Previous Close$199.59
Day High$206.67
Day Low$200.20
52W High$205.97
52W Low$121.05
Volume—
Avg Volume1.05M
Market Cap29.02B
P/E Ratio21.16
EPS$9.32
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$179.51
Above
SMA 200
$150.33
Above
RSI (14)
64.3
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
44 analysts
Price Target
-54.7% upside
Current
$201.96
$201.96
Target
$91.45
$91.45
$57.23
$91.45 avg
$114.90
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 9.93B | 10.02B | 3.09B |
| Net Income | 1.30B | 1.18B | 745.08M |
| Profit Margin | 13.1% | 12.4% | 24.1% |
| EBITDA | 2.24B | 2.15B | 1.15B |
| Free Cash Flow | — | — | 775.19M |
| Rev Growth | -0.9% | -0.9% | +20.7% |
| Debt/Equity | 0.34 | 0.34 | 1.02 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $243.14 | +3.51% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.82 | +0.40% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $123.84 | -1.05% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $480.18 | +1.05% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $620.14 | -0.53% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.17 | -0.30% | 64.3 | 37.13B |